Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Healthcare workers with a positive COVID-19 test were more likely to report long-COVID symptoms.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

The study has limitations, and future research should use better methods to improve treatment for children with hair loss.

Nanofat injections can significantly improve hair growth in men with hair loss for up to a year.

Healthcare workers with COVID-19 reported more long-term symptoms, and physical activity may help reduce some of these symptoms.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Adults with alopecia areata have a higher risk of mental health issues, especially women after COVID-19.

Dermoscopy is useful for diagnosing lichen planopilaris and certain features may relate to disease duration, age, and gender.

Post-exposure syndromes are persistent conditions caused by past exposures, needing unique interventions.

Post-Exposure Syndromes are persistent conditions caused by past exposures, needing unique interventions.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

The Rotterdam Study aims to understand various diseases in older adults.

Obese children respond worse to CARP treatment than non-obese children.

Eight blood metabolites are linked to causing allergic conjunctivitis, offering new ways to predict and treat it.

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.

Long-term, low-dose finasteride may reduce the risk of benign prostatic hyperplasia and prostate cancer.

The severity of female pattern hair loss is linked to how long someone has had it, not to levels of certain nutrients or hormones.

Hematopoietic stem cell transplantation does not significantly affect COVID-19 severity in children with immune disorders.

Clinical pharmacists are crucial in improving patient safety by reporting medication errors in hospitals.